REFERENCES
- Vaddi H., Wang P., Chan S. Effect of some enhancer on the permeation of haloperidol through rat skin in vitro. Int. J. Pharm 2001; 212: 247–255, [INFOTRIEVE], [CSA]
- Vaddi H., Ho P., Chan S. Terpenes in ethanol: haloperidol permeation and partition through human skin and stratum corneum changes. J. Control. Release 2002; 81: 121–133, [INFOTRIEVE], [CSA], [CROSSREF]
- Thacharodi D., Rao K.R. Transdermal absorption of nifedipine from microemulsions of lipophilic skin penetration enhancers. Int. J. Pharm 1994; 111: 235–240, [CSA], [CROSSREF]
- Kim A., Green P.G., Rao G., Guy R.H. Convective solvent flow across the skin during iontophoresis. Pharm. Res 1993; 10(9)1315–1321, [INFOTRIEVE], [CSA], [CROSSREF]
- Rao G., Guy R., Glikfel P., La Course W.R. Reverse iontophoresis: noninvasive glucose monitoring in vivo in human. Pharm. Res 1995; 12(12)1869–1873, [INFOTRIEVE], [CSA], [CROSSREF]
- Álvarez-Figueroa M.J., Delgado-Charro M.B., Blanco-Méndez J. Passive and iontophoretic transdermal penetration of methotrexate. Int. J. Pharm 2001; 212: 101–107, [CSA], [CROSSREF]
- Cheng Y.M., Illum L., Davis S.S. A poly (D, L-lactide-co-glycolide) microsphere depot system for delivery of haloperidol. J. Control. Release 1998; 6: 85–97, [CSA]
- Reynols J.E.F. Martindale the Extra Pharmacopeia 31stThe Pharmaceutical Press, London 1996; 714–715
- Almirall M., Montana J., Escribano E., Obach R., Berrozpe J.D. Effect of D-limonene, α-pinene and cineole on in vitro transdermal human skin penetration of chlorpromazine and haloperidol. Drug Res 1996; 46: 676–680, [CSA]
- Green P.G. Iontophoretic delivery of peptide drugs. J. Control. Release 1996; 41: 33–48, [CSA], [CROSSREF]
- Yoshida N.H., Roberts M.S. Structure-transport relationships in transdermal iontophoresis. Adv. Drug Deliv. Rev 1992; 9: 239–264, [CSA], [CROSSREF]
- Gao S., Singh J. In vitro absorption enhancement of a lipophilic drug tamoxifen by terpenes. J. Control. Release. 1998; 51: 193–199, [INFOTRIEVE], [CSA], [CROSSREF]
- Touitou E., Meidan V.M., Horwitz E. Methods for quantitative determination of drug localized in the skin. J. Control. Release 1998; 56: 7–21, [INFOTRIEVE], [CSA], [CROSSREF]
- Walter M., Hulme T.A., Rippon M.G., Walmsley R.S., Gunnigle S., Lewin M., Winnsey S. In vitro model(s) for the percutaneous delivery of active tissue repair agents. Pharm. Sci 1997; 86(12)1381–1384, [CSA]
- Green P.G., Hinz R.S., Cullander C., Yamane G., Guy R.H. Iontophoretic delivery of amino acids and amino acid derivates across the skin in vitro. Pharm. Res 1991; 8(9)113–118, [CSA]
- A.C. Moffat, M.D. Osselton, B. Widdop, L.Y. GalichetClarke's Analysis of Drugs and Poisons, . Pharmaceutical Press. 2004
- Mills P.C., Magnusson B.M., Cross S.E. Effect of solute lipophilicity on penetration through canine skin. Aust. Vet. J 2003; 12: 752–755, [CSA]
- Kasting G.B., Keister J.C. Application of electrodiffusion theory for a homogeneous membrane to iontophoretic transport through skin. J. Control Release 1989; 8: 195–210, [CSA], [CROSSREF]
- Padmanabhan R.V., Phipps J.B., Lattin G.A., Sawchuk R.J. In vitro and in vivo evaluation of transdermal ionthophoretic delivery of hydromorphone. J. Control. Release 1990; 11: 123–135, [CSA], [CROSSREF]
- Delgado-Charro M.B., Guy R.H. Characterization of convective solvent flow during iontophoresis. Pharm. Res 1994; 11(7)929–935, [INFOTRIEVE], [CSA], [CROSSREF]
- Pikal M.J. The role of electroosmotic flow in transdermal iontophoresis. Adv. Drug Deliv. Rev 1992; 9: 201–237, [CSA], [CROSSREF]